This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 22-25, 2026
Hynes Convention CenterBoston, USA

Dr Benjamin Ko
Associate Director, Development Operations Drug Substance at Boehringer Ingelheim
Speaker

Profile

Benjamin Ko, Ph.D., is Associate Director of Development Operations Drug Substance at Boehringer Ingelheim in Fremont, California. In this role, he is responsible for helping to lead development and tech transfer of biologics production processes, with a focus on downstream operations. He has over 15 years of experience in the biopharmaceutical industry, including early- and late-stage purification development and scale-up, tech transfer and manufacturing support, and viral clearance validation. Prior to joining Boehringer Ingelheim, Benjamin worked at AbbVie Stemcentrx and Genentech. Benjamin holds a Ph.D. in Chemical Engineering from Stanford University.

Agenda Sessions

  • Leveraging Large-scale Manufacturing Experience To Improve Scalability of Resin Lifetime Studies

    11:30am